| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $76,647,892 ) (Continued on the next page) |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21NS143130 | Methotrexate effects on synaptic plasticity: a path to female resiliency to chemotherapy-induced cognitive deficits | 000 | 1 | NIH | 5/14/2025 | $445,500 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM146890 | Role of the neurovascular molecule Wnt in regulating CNS inflammatory responses | 000 | 4 | NIH | 6/17/2025 | $405,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS121077 | The role of VAMP2 in alpha-synuclein function and pathology | 000 | 5 | NIH | 3/28/2025 | $338,050 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K23HL151816 | Sex Disparities in Cardiovascular Disease and Optimal Coronary Revascularization in Dialysis Patients | 000 | 5 | NIH | 4/23/2025 | $194,230 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01AI172959 | Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir | 000 | 3 | NIH | 2/12/2025 | $537,517 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R03NS144870 | Role of NK cell subsets in an animal model of relapsing-remittingmultiple sclerosis | 000 | 1 | NIH | 7/30/2025 | $81,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R03CA304041 | Targeting the HER Family in KRAS Mutant Colorectal Cancer | 000 | 1 | NIH | 7/17/2025 | $162,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA273586 | Roles of Glial Autophagy in Breast Cancer Brain Metastasis | 001 | 3 | NIH | 5/22/2025 | $39,240 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA273586 | Roles of Glial Autophagy in Breast Cancer Brain Metastasis | 000 | 3 | NIH | 2/13/2025 | $353,169 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS140155 | Metabolomics of ICH recovery (METABOL-ICH) | 000 | 1 | NIH | 5/14/2025 | $669,092 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AI182544 | Characterization of cAMP signaling microdomains in the human pathogen Trypanosoma cruzi | 000 | 1 | NIH | 7/1/2025 | $444,688 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01DA063296 | Single cell opioid (fentanyl) responses in the context of HIV | 000 | 1 | NIH | 7/3/2025 | $587,188 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | K01DA054339 | Circuit-Selective Astroglial Plasticity During Opioid Relapse | 002 | 4 | NIH | 7/2/2025 | $183,546 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01AG084834 | Optimizing CNS DHA delivery in elderly adults at risk for dementia | 001 | 2 | NIH | 8/13/2025 | $717,369 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | T35DK060444 | Short-Term Institutional Research Training Grant | 002 | 22 | NIH | 7/3/2025 | $108,663 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U01CA267985 | Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacy | 001 | 4 | NIH | 5/22/2025 | $36,954 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | U01CA267985 | Optimization of peripheral blood mononuclear cell (PBMC) processing for robust downstream functional immune cell analysis and correlation with therapeutic efficacy | 000 | 4 | NIH | 1/28/2025 | $332,592 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R37CA272854 | Investigating the molecular mechanisms of growth in GNAS mutant pancreatic cancer. | 000 | 4 | NIH | 8/15/2025 | $370,575 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL168464 | A novel strategy for heart failure therapeutics | 000 | 2 | NIH | 11/8/2024 | $481,436 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS121426 | Monitoring rapid guanosine signaling during ischemia | 000 | 5 | NIH | 1/28/2025 | $350,086 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01DK106364 | On the regulation of hepatic glucose metabolism during insulin-induced hypoglycemia | 001 | 9 | NIH | 7/10/2025 | $61,943 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01DK106364 | On the regulation of hepatic glucose metabolism during insulin-induced hypoglycemia | 000 | 9 | NIH | 1/8/2025 | $557,488 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21HL172156 | Patient centered outcome measures and prediction tools in lymphangioleiomyomatosis | 000 | 2 | NIH | 1/14/2025 | $123,917 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01EB035594 | Designing a deployable and adaptable plasmonic sensing platform for infectious disease surveillance | 000 | 2 | NIH | 4/15/2025 | $326,891 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM149538 | Novel regulators of macrophage function to repair sterile inflammation-induced heart injury | 002 | 3 | NIH | 8/5/2025 | $44,519 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM149538 | Novel regulators of macrophage function to repair sterile inflammation-induced heart injury | 001 | 3 | NIH | 3/21/2025 | $400,672 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R35GM151170 | Molecular regulation of the CRAC channel signaling pathway | 000 | 3 | NIH | 4/29/2025 | $405,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS134804 | Developing multi-cue piezoelectric PVDF-TrFE biomaterials for peripheral nerve repair | 000 | 2 | NIH | 12/19/2024 | $410,896 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS137887 | No REST for 5-HT Neurons Following Traumatic Brain Injury | 000 | 2 | NIH | 8/8/2025 | $405,000 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 002 | 26 | NIH | 3/20/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 002 | 26 | NIH | 3/20/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 000 | 26 | NIH | 1/17/2025 | $848,076 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 000 | 26 | NIH | 1/17/2025 | $6,951,611 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 005 | 26 | NIH | 7/30/2025 | $723,623 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 003 | 26 | NIH | 7/9/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 003 | 26 | NIH | 7/9/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 004 | 26 | NIH | 7/22/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 004 | 26 | NIH | 7/22/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 001 | 26 | NIH | 2/25/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | UG1DA013732 | The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | 001 | 26 | NIH | 2/25/2025 | $0 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | F31HL175976 | The Role of Platelet-Derived Transforming Growth Factor Beta in Abdominal Aortic Aneurysm | 000 | 2 | NIH | 8/13/2025 | $49,524 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | F31HL176101 | The Role of c-ABL in Mediating TIE2 Signaling and Formation of Venous Malformation | 000 | 2 | NIH | 8/14/2025 | $46,950 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R21AG085052 | The cell-specific neurodegenerative potential of mitochondria post-traumatic brain injury | 000 | 2 | NIH | 7/28/2025 | $239,172 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01NS119827 | Regulation of Angpt1 and DIPG blood-brain barrier integrity by H3K27M mutations | 000 | 4 | NIH | 11/19/2024 | $367,240 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA259845 | Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer | 001 | 4 | NIH | 6/18/2025 | $40,203 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01CA259845 | Fatty acid metabolism regulates ferroptosis in mutant KRAS lung cancer | 000 | 4 | NIH | 12/16/2024 | $361,832 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL156954 | Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis | 001 | 4 | NIH | 8/5/2025 | $61,494 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | R01HL156954 | Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis | 000 | 4 | NIH | 11/20/2024 | $553,447 |
| | 2025 | 2025 | CINCINNATI UNIV OF | 2600 CLIFTON AVE | CINCINNATI | OH | 45220-2872 | HAMILTON | USA | T32GM149200 | Medical Scientist Training Program | 000 | 3 | NIH | 8/1/2025 | $1,050,811 |
|
